Key Metrics
CiteScore 

5.9
Eigenfactor 

0.001 - 0.005
H-Index 

57
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Cardiovascular Drugs
American Journal of Cardiovascular Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Cardiovascular Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Cardiovascular Drugs
Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis.
- 1 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Contemporary Antianginal Therapy.
- 1 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Beta-Blockers After Myocardial Infarction Without Reduced Ejection Fraction: A Meta-Analysis of Kaplan-Meier Reconstructed Individual Patient Data.
- 19 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.
- 16 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile.
- 13 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions.
- 25 Jan 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis.
- 1 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Contemporary Antianginal Therapy.
- 1 Mar 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Beta-Blockers After Myocardial Infarction Without Reduced Ejection Fraction: A Meta-Analysis of Kaplan-Meier Reconstructed Individual Patient Data.
- 19 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.
- 16 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile.
- 13 Feb 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions.
- 25 Jan 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions